Level IIb lymph node metastasis in transglottic laryngeal squamous cell carcinoma | Zendy

Yılmaz Özkul | Zendy; Rıza Dündar | Zendy; Abdülkadir İmre | Zendy; Seçil Arslanoğlu | Zendy; Elif Dinçer | Zendy; Düzgün Ateş | Zendy; Ercan Pınar | Zendy; Kazım Önal | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Level IIb lymph node metastasis in transglottic laryngeal squamous cell carcinoma

Author(s) -

Yılmaz Özkul,

Rıza Dündar,

Abdülkadir İmre,

Seçil Arslanoğlu,

Elif Dinçer,

Düzgün Ateş,

Ercan Pınar,

Kazım Önal

Publication year - 2016

Publication title -

ent updates

Language(s) - English

Resource type - Journals

ISSN - 2149-7109

DOI - 10.2399/jmu.2016002002

Subject(s) - lymph node metastasis , medicine , basal cell , laryngeal neoplasm , metastasis , lymph node , oncology , carcinoma , cancer research , cancer

The treatment of laryngeal squamous cell carcinoma (SCC) is based on proper design of therapeutic strategies aimed to control cervical lymph node metastasis. Cervical nodal metastasis is one of the most important prognostic factors in carcinoma of the larynx. The incidence of clinically detectable lymph node metastasis in laryngeal carcinoma is high, and the levels II, III, and IV are the most commonly involved lymphatic groups in carcinoma of the larynx. Clinical Research

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research